Mister Spex (MRX) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
19 Aug, 2026Executive summary
Adjusted EBITDA rose 65% year-over-year to €3.8 million in H1 2026, with gross margin up 197 bps to 56.9%.
Total net revenue for H1 2026 was €87.9 million, down 10% year-over-year, in line with guidance and reflecting market headwinds and online segment weakness.
Offline revenue grew 10% to €35.1 million, supported by store acquisitions and new openings, while online revenue declined 20–21% due to shop closures and reduced promotions.
Strategic initiatives included outsourcing logistics and production, launching Mister Spex Kids, consolidating payment providers, and expanding B2B2C partnerships.
The company outperformed the German optic market, which saw a 7.4% revenue decline and 11.3% drop in unit sales.
Financial highlights
Q2 2026 net revenue was €47.1 million, down 11% year-over-year, with adjusted EBITDA for Q2 at €2.6 million and gross margin up to 55.4%.
Cash and cash equivalents stood at €43.2 million at quarter-end, with year-end guidance of €25–30 million.
Net loss for H1 2026 widened to €13.6 million, reflecting restructuring and impairment costs.
Adjusted EBITDA margin improved to 5.5% in Q2 2026, up from 3% year-over-year.
Average order value increased 11% to €119, while active customers declined 22% to 1.03 million.
Outlook and guidance
Full-year 2026 guidance confirmed: net revenue expected between 0% and -10% year-over-year, with adjusted EBITDA margin forecasted between breakeven and mid-single-digit percentage.
Year-end cash expected at €25–30 million, with higher working capital and non-recurring cash effects in H2.
Revenue stabilization and premium lens expansion are key priorities for H2.
Ongoing geopolitical risks and economic uncertainty could impact results.
Latest events from Mister Spex
- Q1 2026 saw earnings and margin gains, led by offline growth and strategic shifts, despite revenue decline.MRX
Q1 2026 - Margin expansion and profitability inflection achieved, with EBIT loss reduced by €59m.MRX
Q4 2025 - Q3 2025 revenue fell 18%, but gross margin and EBIT improved sharply amid ongoing transformation.MRX
Q3 2025 - Gross margin rose to 55.0% as cost discipline offset revenue declines and losses narrowed.MRX
Q2 2025 - Gross margin rose to 48.8% as restructuring drove losses and international sales fell 17%.MRX
Q3 2024 - Profitability challenges prompt transformation and rebranding amid modest revenue growth.MRX
H1 2024 - Gross margin rose to 56.4% and EBIT loss narrowed, despite a 13% revenue drop.MRX
Q1 2025 - Restructuring led to a 3% revenue drop and wider losses in 2024; EBIT to improve in 2025.MRX
H2 2024